MoffettNathanson trimmed its target but kept buy; Needham downgraded to hold. Netflix cut its 2026 ad revenue forecast to ...

Western Digital rose 3.9% Wednesday as BofA raised its target to $800 and Morgan Stanley cut to $643, both keeping bullish ...

Bernstein analyst James Hooper reaffirmed a Buy rating on BASF on Tuesday, holding his price target at 61 euros. The ...

BioNTech plans to amend Phase 3 ROSETTA Breast-01 to test pumitamig with Gilead's Trodelvy instead of chemotherapy; the change needs regulatory approval.

Ocugen will report Q3 2026 results on 4 November 2026, a checkpoint on its OCU400 timeline and Roots licensing deal.

BP shares sit 1.4% below their 52-week high after a 3.65% Friday gain, as Q3 refining margins nearly doubled and net debt is ...

About 2,000 trade unionists rallied in Strasbourg against the EU Inc draft, demanding binding guarantees for workers' rights as a committee vote slipped to 5 November.

Plug Power's stock closed Monday at 1.23 euros, hovering just above its 52-week low of 1.21 euros — a valuation that says more about the market's mood on hydrog ...

Ocugen confirmed 140 patients enrolled in the liMeliGhT Phase 3 trial of OCU400, with the primary endpoint now measured using ...

IonQ shares climbed 8.7% in yesterday's session, riding a rebound across quantum computing names that followed a selloff ...

Moderna shares have been on a tear, and the reasons behind that run are worth separating into what has already happened and ...

TSMC has attached a firm condition to any further American manufacturing footprint: whoever builds the chips, TSMC runs the ...